BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vuorio A, Kaste M, Kovanen PT. Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke. eNeurologicalSci 2021;23:100344. [PMID: 33937536 DOI: 10.1016/j.ensci.2021.100344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Liu C, Yan W, Shi J, Wang S, Peng A, Chen Y, Huang K. Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19. Front Nutr 2022;9:927092. [DOI: 10.3389/fnut.2022.927092] [Reference Citation Analysis]
2 Vuorio A, Raal F, Ijäs P, Kaste M, Kovanen PT. Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia. Front Pharmacol 2022;13:890141. [PMID: 35645833 DOI: 10.3389/fphar.2022.890141] [Reference Citation Analysis]
3 Song Y, Liu J, Zhao K, Gao L, Zhao J. Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases. Cell Metab 2021;33:1911-25. [PMID: 34562355 DOI: 10.1016/j.cmet.2021.09.001] [Reference Citation Analysis]
4 Vuorio A, Kovanen PT, Santos RD, Raal F. Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge. Cardiol Ther 2021. [PMID: 34787816 DOI: 10.1007/s40119-021-00245-3] [Reference Citation Analysis]